retatrutide phase 3 results october 2025 approval: FDA status, clinical trial results, and when it could be available Pipeline Report 2025: Late-stage programs

The STEP trials demonstrated that participants lost an average of 10-15% of their body weight over 68 weeks, depending on lifestyle adherence and consistency with medication

Given the well-established link between excess adiposity and chronic low-grade inflammation, researchers are exploring whether its significant weight-reducing effects may translate into measurable reductions in inflammatory markers

Begin hydrating heavily 12 days before your first injection, maintain consistent small meals, avoid alcohol, and review any blood pressure medications with your provider

Starting July 1, 2026, CMS announced it will provide eligible Medicare beneficiaries access to certain GLP-1 medications for $50 per month

GLP-1s blueprint was finally decoded: it was not an independent molecule, but a fragment snipped from a larger protein called proglucagon

Others want a natural look and feel or to only use their own tissue, making fat grafting attractive